ImageneBio Inc (IMA) — Financial statements
Income statement, balance sheet, and cash flow for ImageneBio Inc — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.80↓77.1% | 4↓61.8% | 9↓41.3% | 16↓49.6% | 31 | |
| Cost of Revenue | 1 | 0.00↓100.0% | 1↓98.4% | 64↑36.5% | 47 | |
| Gross Profit | -0.23↓106.7% | 4↓57.0% | 8↑116.7% | -49↓202.1% | -16 | |
| Operating Expenses | ||||||
| R&D Expenses | 29↓11.2% | 32↓46.2% | 60↓7.3% | 64↑36.5% | 47 | |
| General & Administrative Expenses | 21↑147.0% | 8↓66.3% | 25↑12.3% | 22↑23.2% | 18 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 21↑147.0% | 8↓66.3% | 25↑12.3% | 22↑23.2% | 18 | |
| Other Expenses | -1 | 0.00↑100.0% | -1↑98.4% | -64↓36.5% | -47 | |
| Operating Expenses | 48↑19.1% | 41↓51.5% | 84↑276.4% | 22↑23.2% | 18 | |
| Total Costs & Expenses | 49↑21.6% | 41↓52.1% | 85↓2.2% | 87↑32.9% | 65 | |
| Operating Results | ||||||
| Operating Income | -48↓30.9% | -37↑50.9% | -75↓6.4% | -71↓107.7% | -34 | |
| Depreciation & Amortization | 1↓32.3% | 2↑49.6% | 1↑35.8% | 0.75↑38.1% | 0.54 | |
| EBITDA | -47↓33.7% | -35↑52.3% | -74↓6.0% | -70↓108.8% | -34 | |
| EBIT | -48↓30.9% | -37↑50.9% | -75↓6.4% | -71↓107.7% | -34 | |
| Interest & Other Income | ||||||
| Net Interest Income | 2↓72.4% | 7↑3.7% | 7↑230.9% | 2↑9243.5% | 0.02 | |
| Interest Income | 2↓72.4% | 7↑3.7% | 7↑230.9% | 2↑9243.5% | 0.02 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 3↑518.4% | 0.45↓93.7% | 7↑231.4% | 2↑9200.0% | 0.02 | |
| Income Before Tax | -46↓25.0% | -37↑46.5% | -68↑0.6% | -69↓101.6% | -34 | |
| Income Tax Expense | -0.35↓2792.3% | 0.01↑108.0% | -0.16 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -45↓24.0% | -37↑46.4% | -68↑0.9% | -69↓101.6% | -34 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -45↓24.0% | -37↑46.4% | -68↑0.9% | -69↓101.6% | -34 | |
| Bottom-Line Net Income | -52↓8.3% | -48↑29.0% | -68↑0.9% | -69↓101.6% | -34 | |
| EPS (Basic) | -10.76↓954.9% | -1.02↑37.4% | -1.63↑14.2% | -1.90↓100.0% | -0.95 | |
| EPS (Diluted) | -10.76↓954.9% | -1.02↑37.4% | -1.63↑14.2% | -1.90↓100.0% | -0.95 | |
| Weighted Average Shares | 5↓89.9% | 48↑15.6% | 42↑15.3% | 36↑0.6% | 36 | |
| Weighted Average Diluted Shares | 5↓89.9% | 48↑15.6% | 42↑15.3% | 36↑0.6% | 36 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.